Origin in the News

Open To The World magazine, Autum 2007

Nothing ventured, nothing gained

By Mary-Eleanor Walker

Origin BioMed is experiencing international growth with support from Canadian venture capital investors … read more

Halifax Chronicle Herald July 2007

Drug manufacturer gets $3.8m

By BILL POWER Staff Reporter

N.S. Business Inc. among investors in Origin BioMed … read more

Halifax Daily News February 2007

Halifax's Origin BioMed Inc. gradually moves new treatment to drug chains

HEALTH SCIENCE By Andrea MacDonald - The Daily News

A national chain asks to sell your product in its stores–all 1,046 of them. You politely turn them down. Corporate suicide? Apparently not … read more

Chain Drug Review, October 23, 2006

Neuragen for nerve damage pain

HALIFAX, Nova Scotia—With the epidemic of diabetes and shingles, it is important that new treatments are available for people suffering from pain due to nerve damage. And more importantly, access to new treatment is paramount.

Origin BioMed Inc., a manufacturer of over-the-counter topical drug products, has partnered with Canada's largest drug chain to provide people suffering from diabetic neuropathy and shingles with its topical pain relief product, Neuragen … read more